Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMISE: Folic Acid and Statins on Carotid Plaque Stability
NCT07680595Phase 2Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Mar 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 2, open-label trial of folic acid in carotid atherosclerotic plaque (CAS) (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Change in Carotid Plaque Thickness at 6 months. Started Mar 2026; status: recruiting.
02
Drugs
folic acid
03
Conditions
carotid atherosclerotic plaque (CAS)
Beyond the preview
Go deeper on NCT07680595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07680595.